STOCK TITAN

Cryoport to Report Third Quarter 2024 Financial Results on November 7, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Cryoport (Nasdaq: CYRX) announced it will release its third quarter 2024 financial results on November 7, 2024 after U.S. markets close. The company will issue a document titled 'Cryoport Third Quarter 2024 in Review' at 4:05 p.m. ET, providing financial and operational performance details. Management will host a Q&A conference call at 5:00 p.m. ET the same day, accompanied by a slide deck. The call will be available for replay until November 14, 2024, accessible via the company's website or dial-in numbers.

Cryoport (Nasdaq: CYRX) ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 il 7 novembre 2024 dopo la chiusura dei mercati statunitensi. L'azienda emetterà un documento intitolato 'Rassegna del terzo trimestre 2024 di Cryoport' alle 16:05 ET, fornendo dettagli sul rendimento finanziario e operativo. La direzione ospiterà una conferenza telefonica di domande e risposte alle 17:00 ET lo stesso giorno, accompagnata da una presentazione. La chiamata sarà disponibile per il replay fino al 14 novembre 2024, accessibile tramite il sito web dell'azienda o i numeri di accesso.

Cryoport (Nasdaq: CYRX) anunció que publicará sus resultados financieros del tercer trimestre de 2024 el 7 de noviembre de 2024 después del cierre de los mercados de EE. UU. La compañía emitirá un documento titulado 'Informe del tercer trimestre 2024 de Cryoport' a las 4:05 p.m. ET, proporcionando detalles sobre el rendimiento financiero y operativo. La dirección llevará a cabo una conferencia telefónica de preguntas y respuestas a las 5:00 p.m. ET el mismo día, acompañada de una presentación en diapositivas. La llamada estará disponible para repetición hasta el 14 de noviembre de 2024, accesible a través del sitio web de la empresa o números de marcación.

Cryoport (Nasdaq: CYRX)는 2024년 3분기 재무 결과를 2024년 11월 7일 미국 시장이 마감된 후 발표할 것이라고 발표했습니다. 회사는 오후 4시 5분 (ET)에 '2024년 3분기 Cryoport 리뷰'라는 제목의 문서를 발행하여 재무 및 운영 성과에 대한 세부 정보를 제공합니다. 경영진은 같은 날 오후 5시에 Q&A 전화 회의를 진행하며 슬라이드 데크도 함께 제공됩니다. 전화 회의는 2024년 11월 14일까지 다시 들을 수 있으며, 회사 웹사이트 또는 다이얼인 번호를 통해 접근할 수 있습니다.

Cryoport (Nasdaq: CYRX) a annoncé qu'il publiera ses résultats financiers pour le troisième trimestre 2024 le 7 novembre 2024 après la fermeture des marchés américains. La société émettra un document intitulé 'Cryoport Bilan du troisième trimestre 2024' à 16h05 ET, fournissant des détails sur la performance financière et opérationnelle. La direction animera une conférence téléphonique de questions et réponses le même jour à 17h00 ET, accompagnée d'une présentation en diaporama. L'appel sera disponible en replay jusqu'au 14 novembre 2024, accessible via le site web de l'entreprise ou les numéros de connexion.

Cryoport (Nasdaq: CYRX) gab bekannt, dass die Finanzzahlen für das dritte Quartal 2024 am 7. November 2024 nach der Schließung der US-Märkte veröffentlicht werden. Das Unternehmen wird ein Dokument mit dem Titel 'Cryoport Rückblick auf das dritte Quartal 2024' um 16:05 Uhr ET veröffentlichen, das Details zur finanziellen und operativen Leistung bereitstellt. Das Management wird am selben Tag um 17:00 Uhr ET eine Q&A-Konferenzschaltung abhalten, die von einer Präsentation begleitet wird. Die Aufzeichnung der Telefonkonferenz wird bis zum 14. November 2024 verfügbar sein und über die Website des Unternehmens oder die Einwahlnummern abgerufen werden können.

Positive
  • None.
Negative
  • None.

NASHVILLE, Tenn., Oct. 29, 2024 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in supply chain solutions for the life sciences industry, today announced that the Company will report financial results for the third quarter ended September 30, 2024 on Thursday, November 7, 2024 after U.S. markets close.

In addition to the earnings release, a document titled "Cryoport Third Quarter 2024 in Review", providing a review of Cryoport's financial and operational performance and a general business update, will be issued at 4:05 p.m. ET on Thursday, November 7, 2024. The document is designed to be read in advance of the questions and answers conference call and will be accessible at https://ir.cryoportinc.com/news-events/ir-calendar.

Cryoport management will host a conference call the same day at 5:00 p.m. ET. The conference call will be in the format of a questions and answers session and will address questions members of the investment community have regarding the Company's reported results. A slide deck will accompany the call.

Conference Call Information

Date:

Thursday, November 7, 2024

Time:

5:00 p.m. ET

Dial-in numbers:

1-800-717-1738 (U.S.), 1-646-307-1865 (International)

Confirmation code:

Request the "Cryoport Call" or Conference ID: 1171580

Live webcast:

'Investor Relations' section at www.cryoportinc.com or click here.

Please allow 10 minutes prior to the call to visit this site to download and install any necessary audio software.

The questions and answers call will be recorded and available approximately three hours after completion of the live event in the Investor Relations section of the Company's website at www.cryoportinc.com for a limited time. To access the replay of the questions and answers click here. A dial-in replay of the call will also be available to those interested, until November 14, 2024. To access the replay, dial 1-844-512-2921 (United States) or 1-412-317-6671 (International) and enter replay entry code: 1171580#.

About Cryoport, Inc
Cryoport, Inc. (Nasdaq: CYRX), is a global leader in supply chain solutions for the Life Sciences with an emphasis on cell & gene therapies. Cryoport enables manufacturers, contract manufacturers (CDMO's), contract research organizations (CRO's), developers, and researchers to carry out their respective business with products and services that are designed to derisk services and provide certainty. We provide a broad array of supply chain solutions for the life sciences industry. Through our platform of critical products and solutions including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, we are "Enabling the Future of Medicine™" worldwide, through our innovative systems, compliant procedures, and agile approach to superior supply chain management.

Our corporate headquarters, located in Nashville, Tennessee, is complemented by over 50 global locations in 17 countries, with key sites in the United States, United Kingdom, France, the Netherlands, Belgium, Portugal, Germany, Japan, Australia, India, and China.

For more information, visit www.cryoportinc.com or follow via LinkedIn at https://www.linkedin.com/company/cryoportinc or @cryoport on X, formerly known as Twitter at www.x.com/cryoport for live updates.

Forward-Looking Statements
Statements in this press release which are not purely historical, including statements regarding Cryoport's intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. It is important to note that Cryoport's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effect of changing economic and geopolitical conditions, supply chain constraints, inflationary pressures, the effects of foreign currency fluctuations, trends in the products markets, variations in Cryoport's cash flow, market acceptance risks, and technical development risks. Cryoport's business could be affected by other factors discussed in Cryoport's SEC reports, including in the "Risk Factors" section of its most recently filed periodic reports on Form 10-K and Form 10-Q, as well as in its subsequent filings with the SEC. The forward-looking statements contained in this press release speak only as of the date hereof and Cryoport cautions investors not to place undue reliance on these forward-looking statements. Except as required by law, Cryoport disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cryoport-to-report-third-quarter-2024-financial-results-on-november-7-2024-302289830.html

SOURCE Cryoport, Inc.

FAQ

When will Cryoport (CYRX) release Q3 2024 earnings?

Cryoport will release its third quarter 2024 financial results on Thursday, November 7, 2024, after U.S. markets close.

What time is Cryoport's (CYRX) Q3 2024 earnings call?

Cryoport's Q3 2024 earnings conference call will be held on Thursday, November 7, 2024, at 5:00 p.m. ET.

How can I access Cryoport's (CYRX) Q3 2024 earnings call?

You can access the call by dialing 1-800-717-1738 (U.S.) or 1-646-307-1865 (International) with Conference ID 1171580, or via the live webcast on Cryoport's website.

Until when will Cryoport's (CYRX) Q3 2024 earnings call replay be available?

The earnings call replay will be available until November 14, 2024, through the company's website or by dialing 1-844-512-2921 (U.S.) or 1-412-317-6671 (International).

CryoPort, Inc.

NASDAQ:CYRX

CYRX Rankings

CYRX Latest News

CYRX Stock Data

329.09M
49.41M
2.5%
112.56%
5.7%
Integrated Freight & Logistics
Pharmaceutical Preparations
Link
United States of America
BRENTWOOD